Le Lézard
Classified in: Health
Subjects: CCA, MAT

Neptune to Participate in Two Upcoming Investor Conferences in November


LAVAL, QC, Nov. 11, 2021 /CNW Telbec/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced that Michael Cammarata, Chief Executive Officer, and Randy Weaver, Interim Chief Financial Officer, are scheduled to participate in two upcoming investor conferences in November.

Jefferies Virtual West Coast Consumer Conference
Date: Wednesday, November 17, 2021
Time: 12:20-1:00 p.m. ET
Link: https://wsw.com/webcast/jeff210/nept/1852866 
Mr. Cammarata will participate in a fireside chat at the Jefferies Virtual West Coast Consumer Conference.

Cowen's 4th Annual Cannabis Conference
Date: 
November 29 - December 1, 2021
Management will be available for virtual one-on-one meetings with institutional and corporate clients of the firm. To find out more, please visit the conference website at https://www.cowen.com/conferences-and-events/4th-annual-cannabis-conference/.

To schedule a meeting with Neptune's management team, please contact KCSA Strategic Communications by emailing [email protected].

About Neptune Wellness Solutions Inc.

Headquartered in Laval, Quebec, Neptune is a diversified health and wellness company with a mission to redefine health and wellness. Neptune is focused on building a portfolio of high quality, affordable consumer products in response to long-term secular trends and market demand for natural, plant-based, sustainable and purpose-driven lifestyle brands. The Company utilizes a highly flexible, cost-efficient manufacturing and supply chain infrastructure that can be scaled to quickly adapt to consumer demand and bring new products to market through its mass retail partners and e-commerce channels. For additional information, please visit: https://neptunewellness.com/.

Disclaimer ? Safe Harbor Forward?Looking Statements

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Neptune Wellness Solutions to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

Neither NASDAQ nor the Toronto Stock Exchange accepts responsibility for the adequacy or accuracy of this release.

SOURCE Neptune Wellness Solutions Inc.


These press releases may also interest you

at 01:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. Food and Drug Administration (FDA) has approved the Vabysmo® (faricimab-svoa) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of wet, or...

4 jui 2024
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is...

4 jui 2024
The global sleep apnea implants market size is estimated to grow by USD 401.75 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.2% during the forecast period. Increasing prevalence of sleep apnea and...

4 jui 2024
The global implantable medical devices market size is estimated to grow by USD 53.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.08% during the forecast period. Rise in number of people with chronic...

4 jui 2024
The global transplant box market size is estimated to grow by USD 2.39 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.87%  during the forecast period. Increasing prevalence of chronic disorders is...

4 jui 2024
DelveInsight's BK Virus Infection Market Insights report includes a comprehensive understanding of current treatment practices, BK virus infection emerging drugs, market share...



News published on and distributed by: